Alumni & Donor Login MyProfile Home Research Education & Training Patient Care Faculty Departments & Centers Newsroom Careers About Us Alumni & Giving Sections MyProfile Alumni Stories Membership Gratitude & Annual Giving Ways to Give Endowments Planned Giving Events Log Into Your Community Once you are logged in, you can access your donor information, and if applicable , the Alumni Directory. If you are a new user, please select " New User Registration " to create your User ID and Password. It

CLINICAL CANCER RESEARCH | CLINICAL TRIALS: TARGETED THERAPY A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2a in Patients with Advanced Clear Cell Renal Cell Carcinoma James Brugarolas1, Gregory Obara2, Kathryn E. Beckermann3, Brian Rini3, Elaine T. Lam4, James Hamilton5, Thomas Schluep5, Min Yi5, So Wong5, Zhongping Lily Mao5, Erick Gamelin6, and Nizar M. Tannir7 ABSTRACT ◥ Purpose: ARO-HIF2 is an siRNA drug designed to selectively target hypoxia

UT Southwestern celebrated its annual Martin Luther King Commemorative Celebration

Discover INSTRUCTOR and other Faculty and Physicians jobs in Dallas, TX and apply online today

Join UT Southwestern for the the Carolyn P. Horchow Women's Health Symposium

Join The Vanguard as we explore the latest advances in using biology and engineering to drive innovation in medicine

COVID-19, coronovirus, giving, virus, needs

Alumni & Donor Login MyProfile Home Research Education & Training Patient Care Faculty Departments & Centers Newsroom Careers About Us Alumni & Giving Sections MyProfile Alumni Stories Membership Gratitude & Annual Giving Ways to Give Endowments Planned Giving Events Step 1 Selection Step 2 Registration Step 3 Payment The Vanguard: New Innovations in Cancer Therapy Tuesday, September 17 6:00 PM - 7:30 PM New innovations in cancer therapy, especially at the interface of radiotherapy and

Discover Myeloma Specialist and other Faculty and Physicians jobs in Dallas, TX and apply online today